Shai Iris, Rimm Eric B, Hankinson Susan E, Curhan Gary, Manson JoAnn E, Rifai Nader, Stampfer Meir J, Ma Jing
Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.
Circulation. 2004 Nov 2;110(18):2824-30. doi: 10.1161/01.CIR.0000146339.57154.9B. Epub 2004 Oct 18.
Over the past decade, lipid measurements have been significantly improved and standardized. We evaluated the usefulness of multiple plasma lipid parameters in predicting coronary heart diseases (CHD) among women.
Among 32,826 women from the Nurses' Health Study who provided blood samples at baseline, 234 CHD events were documented during 8 years of follow-up. In a nested study, these cases were matched to controls (1:2) for age, smoking, fasting status, and month of blood draw. We estimated the relative risk (RR) for each lipid parameter, adjusted for C-reactive protein, homocysteine, body mass index, family history, hypertension, diabetes, postmenopausal hormone use, physical activity, alcohol intake, and blood draw parameters. The RRs associated with an increase of approximately 1 SD (mg/dL) were as follows: HDL cholesterol (HDL-C) (RR=0.6 [0.5 to 0.8], SD=17), apolipoprotein B100 (apoB100) (RR=1.7 [1.4 to 2.1], SD=32), LDL cholesterol (LDL-C) (RR=1.4 [1.1 to 1.7], SD=36), total cholesterol (TC) (RR=1.4 [1.1 to 1.6], SD=40), and triglycerides (RR=1.3 [1.0 to 1.5], SD=80). Among the lipid indexes, the RRs were: apoB100/HDL-C (RR=1.7 [1.4 to 2.1], SD=1.0), TC/HDL-C (RR=1.6 [1.3 to 1.9], SD=1.3), LDL-C/HDL-C (RR=1.5 [1.3 to 1.9], SD=1.0), and non-HDL-C (RR=1.6 [1.3 to 1.9], SD=42 mg/dL). After simultaneous control for several lipid biomarkers, HDL-C was the primary contributor of the variation in multivariate models (P=0.01), followed by LDL-C (P=0.01), whereas triglycerides and apoB100 did not contribute further information. HDL-C-related ratios were the strongest contributors to predicting CHD (P<0.0001).
Lower levels of HDL-C may be a key discriminator of higher CHD events among postmenopausal women. HDL-C-related ratios (such as TC/HDL-C) provide a powerful predictive tool independently of other known CHD risk factors.
在过去十年中,血脂测量有了显著改善并实现了标准化。我们评估了多种血浆脂质参数在预测女性冠心病(CHD)方面的效用。
在护士健康研究中,32826名在基线时提供血样的女性中,在8年随访期间记录了234例冠心病事件。在一项巢式研究中,将这些病例与对照(1:2)按年龄、吸烟、空腹状态和采血月份进行匹配。我们估计了每个脂质参数的相对风险(RR),并对C反应蛋白、同型半胱氨酸、体重指数、家族史、高血压、糖尿病、绝经后激素使用、身体活动、酒精摄入和采血参数进行了调整。与增加约1个标准差(mg/dL)相关的RR如下:高密度脂蛋白胆固醇(HDL-C)(RR = 0.6 [0.5至0.8],SD = 17),载脂蛋白B100(apoB100)(RR = 1.7 [1.4至2.1],SD = 32),低密度脂蛋白胆固醇(LDL-C)(RR = 1.4 [1.1至1.7],SD = 36),总胆固醇(TC)(RR = 1.4 [1.1至1.6],SD = 40),以及甘油三酯(RR = 1.3 [1.0至1.5],SD = 80)。在脂质指标中,RR分别为:apoB100/HDL-C(RR = 1.7 [1.4至2.1],SD = 1.0),TC/HDL-C(RR = 1.6 [1.3至1.9],SD = 1.3),LDL-C/HDL-C(RR = 1.5 [1.3至1.9],SD = 1.0),以及非HDL-C(RR = 1.6 [1.3至1.9],SD = 42 mg/dL)。在同时控制了几种脂质生物标志物后,HDL-C是多变量模型中变异的主要贡献者(P = 0.01),其次是LDL-C(P = 0.01),而甘油三酯和apoB100没有提供更多信息。与HDL-C相关的比率是预测冠心病的最强贡献者(P < 0.0001)。
较低水平的HDL-C可能是绝经后女性冠心病事件较高的关键鉴别因素。与HDL-C相关的比率(如TC/HDL-C)独立于其他已知的冠心病危险因素提供了一个强大的预测工具。